This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Sysmex Corporation. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Emi Kanemura: Innovator in Cell Analysis Technology
Introduction
Emi Kanemura is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of cell analysis technology. Her innovative work has led to the development of a unique patent that enhances the quality control processes in clinical settings.
Latest Patents
Emi Kanemura holds a patent for a "Cell analyzer, cell collecting apparatus, and quality control method including processing and analyzing quality control particles." This invention features a measuring device that collects target cells from a specimen using a filter. It is designed to measure the collected target cells and analyze them based on the measurement data. The cell analyzer operates in two modes: one for clinical specimens and another for quality control specimens. The data processing device is programmed to monitor the amount of particles collected and can trigger an alarm when specific conditions are met. This innovation is crucial for ensuring the accuracy and reliability of cell analysis in medical diagnostics.
Career Highlights
Emi Kanemura is currently employed at Sysmex Corporation, a leading company in the field of medical diagnostics and laboratory testing. Her work at Sysmex has allowed her to focus on advancing technologies that improve patient care and laboratory efficiency.
Collaborations
Emi collaborates with talented colleagues, including Ryuichiro Ebi and Kohei Murakami. Their combined expertise contributes to the innovative projects at Sysmex Corporation.
Conclusion
Emi Kanemura's contributions to cell analysis technology exemplify her dedication to improving medical diagnostics. Her innovative patent reflects her commitment to enhancing quality control in clinical settings. Through her work, she continues to make a significant impact in the field of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
